|
Systemic Sclerosis
Citations 221-230 of 242 total displayed.
|
Past content
(since Jan 2001):
|
- Original Papers
Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis
- M. E. Anderson, T. L. Moore, S. Hollis, M. I. V. Jayson, T. A. King, and A. L. Herrick
Rheumatology 2002; 41: 324-328.
[Abstract]
[Full Text]
- Letters to the Editor
Long-term treatment of patients affected by systemic sclerosis with cyclosporin A
- G. Filaci, M. Cutolo, M. Basso, G. Murdaca, L. Derchi, R. Gianrossi, F. Ropolo, P. Zentilin, A. Sulli, F. Puppo, and F. Indiveri
Rheumatology 2001; 40: 1431-1432.
[Extract]
[Full Text]
- Original Papers
Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells
- Y. Allanore, D. Borderie, P. Hilliquin, A. Hernvann, M. Levacher, H. Lemaréchal, O. G. Ekindjian, and A. Kahan
Rheumatology 2001; 40: 1089-1096.
[Abstract]
[Full Text]
- Original Papers
Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody
- M. C. Wan, T. Moore, S. Hollis, and A. L. Herrick
Rheumatology 2001; 40: 1102-1105.
[Abstract]
[Full Text]
- Original Papers
Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis
- S. Sato, Y. Hamaguchi, M. Hasegawa, and K. Takehara
Rheumatology 2001; 40: 1135-1140.
[Abstract]
[Full Text]
- Original Papers
Anti-fibrillarin antibodies in systemic sclerosis
- V. J. Tormey, C. C. Bunn, C. P. Denton, and C. M. Black
Rheumatology 2001; 40: 1157-1162.
[Abstract]
[Full Text]
- Letters to the Editor
Anti-thymocyte globulin in scleroderma
- A. M. Denman, R. Stratton, H. Wilson, and C. Black
Rheumatology 2001; 40: 1192.
[Extract]
[Full Text]
- Report
Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups
- P. Brooks and M. Hochberg
Rheumatology 2001; 40: 896-906.
[Extract]
[Full Text]
- Original Papers
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial
- D. E. Furst, P. J. Clements, W. K. Wong, M. D. Mayes, F. Wigley, B. White, M. Weisman, W. Barr, L. Moreland, R. Martin, T. A. Medsger, Jr, V. Steen, D. Collier, A. Weinstein, E. Lally, J. Varga, S. R. Weiner, B. Andrews, M. Abeles, J. B. Peter, and J. R. Seibold
Rheumatology 2001; 40: 615-622.
[Abstract]
[Full Text]
- Original Papers
Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma
- K. Yamane, H. Ihn, M. Kubo, M. Kuwana, Y. Asano, N. Yazawa, and K. Tamaki
Rheumatology 2001; 40: 683-686.
[Abstract]
[Full Text]
|
|
